Related Experiment Video
Updated: Jul 18, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
Antiphospholipid syndrome mimicking multiple sclerosis in two patients
Francisco J Fernández-Fernández1, Alberto Rivera-Gallego, Javier de la Fuente-Aguado
1Servicio de Medicina Interna, Complexo Hospitalario Universitario de Vigo, R/ Pizarro 22, 36204 Vigo (Pontevedra), Spain.
Antiphospholipid syndrome can mimic multiple sclerosis, causing diagnostic challenges. Anticoagulant therapy effectively prevented new neurological events in two patients with antiphospholipid syndrome and demyelinating lesions.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Background:
- Antiphospholipid syndrome (APS) is an autoimmune disorder.
- APS can present with neurological symptoms that overlap with other conditions.
- Diagnostic challenges arise when APS mimics other neurological diseases like multiple sclerosis.
Purpose of the Study:
- To highlight the diagnostic challenges of antiphospholipid syndrome mimicking multiple sclerosis.
- To present cases of young women with neurological deficiencies, antiphospholipid antibodies, and demyelinating lesions.
- To evaluate the efficacy of anticoagulant therapy in managing neurological events in APS.
Main Methods:
- Case report of two young women.
- Clinical assessment of recurrent neurological deficiencies.
- Laboratory testing for antiphospholipid antibodies.
- Magnetic resonance imaging (MRI) to identify demyelinating lesions.
Main Results:
- Both patients exhibited recurrent neurological deficits.
- Antiphospholipid antibodies were detected in both patients' serum.
- MRI revealed demyelinating lesions consistent with neurological autoimmune conditions.
- Anticoagulant therapy was initiated in both cases.
- No new neurological events occurred after initiating anticoagulant therapy.
Conclusions:
- Antiphospholipid syndrome should be considered in the differential diagnosis of patients presenting with neurological symptoms and demyelinating lesions.
- Early diagnosis and initiation of anticoagulant therapy may prevent further neurological complications in APS.
More Related Videos
05:44Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
08:40Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021